obesity drug news today glp-1 september 2025 Nimacimab boosts weight loss with without side effects | Professor Erwin Loh posted on the topic Obesity GLP-1 Market Size to

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): A prospective-randomized study in middle aged men and women

It helps create a sense of fullness without overeating

This article addresses the concerns of individuals with a valid prescription

At the same time, there is growing recognition that GLP-1 therapy reduces hepatic steatosis, triglycerides, and systemic inflammation

Shortages And Supply Chain Updates In 2025 For the past few years, drug shortages have been a major issue for patients trying to access GLP-1s

Competitor GLP-1 meds include two forms of the Novo Nordisk drug semaglutide: Ozempic (for diabetes) and Wegovy (for weight loss)